oxybutynin has been researched along with Airflow Obstruction, Chronic in 4 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment-naïve patients with COPD (n = 36) were prospectively treated with two kinds of LABA--inhaled salmeterol and transdermal tulobuterol patch--for 12 weeks in crossover study, and changes in pulmonary function data and 6-minute walk distance (6 MWD) were compared between groups stratified by the CysGlyGln." | 2.77 | β2-adrenergic receptor haplotype may be associated with susceptibility to desensitization to long-acting β2-agonists in COPD patients. ( Kawate, E; Mochizuki, H; Nanjo, Y; Takahashi, H; Tsuda, Y; Yamazaki, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berlin, I | 1 |
| Jacob, N | 1 |
| Coudert, M | 1 |
| Perriot, J | 1 |
| Schultz, L | 1 |
| Rodon, N | 1 |
| Abe, T | 1 |
| Setoguchi, Y | 1 |
| Kono, Y | 1 |
| Togashi, Y | 1 |
| Sugiyama, S | 1 |
| Tanakadate, M | 1 |
| Soeda, S | 1 |
| Nakai, M | 1 |
| Sugiyama, N | 1 |
| Fujiwara, A | 1 |
| Yamaguchi, K | 1 |
| Yamaguchi, A | 1 |
| Kurita, N | 1 |
| Tamura, G | 1 |
| Ichinose, M | 1 |
| Fukuchi, Y | 1 |
| Miyamoto, T | 1 |
| Mochizuki, H | 1 |
| Nanjo, Y | 1 |
| Kawate, E | 1 |
| Yamazaki, M | 1 |
| Tsuda, Y | 1 |
| Takahashi, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Does Dose Adjustment of Nicotine Replacement Therapies According to Saliva Cotinine Increase Efficacy of These Treatments of Assistance To the Nicotinic Weaning Of the High-Risk Patients?[NCT00235313] | Phase 4 | 300 participants (Actual) | Interventional | 2005-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for oxybutynin and Airflow Obstruction, Chronic
| Article | Year |
|---|---|
Transdermal tulobuterol patch, a long-actingβ(2)-agonist.
Topics: Adrenergic beta-Agonists; Asthma; Bronchodilator Agents; Drug Approval; Evidence-Based Medicine; Hum | 2012 |
3 trials available for oxybutynin and Airflow Obstruction, Chronic